Bavarian Nordic A/S  

(Public, CPH:BAVA)   Watch this stock  
Find more results for BAVA
0.00 (0.00%)
Apr 20 - Close
CPH real-time data - Disclaimer
Currency in DKK
Range     -
52 week 100.00 - 393.00
Open     -
Vol / Avg. 0.00/293,567.00
Mkt cap 9.39B
P/E 383.44
Div/yield     -
EPS 0.88
Shares 27.73M
Beta     -
Inst. own     -
Apr 15, 2015
Bavarian Nordic A/S at Needham Healthcare Conference
Mar 11, 2015
Q4 2014 Bavarian Nordic A/S Earnings Call
Mar 11, 2015
Q4 2014 Bavarian Nordic A/S Earnings Release
Mar 2, 2015
Bavarian Nordic A/S at Cowen Health Care Conference

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 18.10% 2.13%
Operating margin 25.49% 1.37%
EBITD margin - 5.06%
Return on average assets 24.93% 1.55%
Return on average equity 36.82% 2.33%
Employees 422 -
CDP Score - -


Hejreskovvej 10A, Munkegarde

Website links


Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. The Company�s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate cancer, including PROSTVAC and Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) PRO; breast cancer, providing CV-301 breast and MVA-BN HER2 vaccines; and colorectal cancer, offering CV-301 colon. The Infectious Disease pipeline produces vaccines for a range of illnesses, such as smallpox, anthrax, filoviruses, foot-and-mouth diseases and respiratory syncytial virus. The Company is a parent of Bavarian Nordic GmbH, BN Infectious Diseases A/S, and Bavarian Nordic Inc, among others.

Officers and directors

Gerard W. M. van Odijk M.D. Independent Chairman of the Board
Age: 58
Paul Chaplin Ph.D. President, Chief Executive Officer
Age: 48
Anders Gersel Pedersen M.D. Independent Deputy Chairman of the Board
Age: 64
Ole Larsen Chief Financial Officer, Executive Vice President
Age: 50
James B. Breitmeyer Executive Vice President and Chief Development Officer
Age: 62
Claus Braestrup Ph.D. Independent Director
Age: 70
Erik Gregers Hansen Independent Director
Age: 63
Peter Kurstein Independent Director
Age: 59